Plx Pharma patents expiration
1. Vazalore patents expiration
VAZALORE Litigations
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9351984 | PLX PHARMA | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Dec, 2021
(2 years ago) | |
| US8865187 | PLX PHARMA | Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Mar, 2022
(2 years ago) | |
| US9101637 | PLX PHARMA | Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
Mar, 2022
(2 years ago) | |
| US9226892 | PLX PHARMA | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(8 years from now) | |
| US9216150 | PLX PHARMA | pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(8 years from now) | |
| US10786444 | PLX PHARMA | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(8 years from now) | |
| US10646431 | PLX PHARMA | PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same |
Sep, 2032
(8 years from now) | |
Drugs and Companies using ASPIRIN ingredient
Market Authorisation Date: 26 February, 2021
Treatment: Temporary relief of minor aches and pains; Temporary reduction of fever; A method of targeting release of a non-steroidal anti-inflammatory drug (nsaid) to the small intestine of the subject when admi...
Dosage: CAPSULE;ORAL
More Information on Dosage
VAZALORE family patents
